Korean J Thorac Cardiovasc Surg.  2005 Jan;38(1):50-55.

Thoracic Actinomycosis

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, Catholic University Medical College, Korea. phenix@catholic.ac.kr

Abstract

BACKGROUND: Thoracic actinomycosis is a rare, chronic debilitating disease and it is difficult to diagnose and treat. MATERIAL AND METHOD: Between March 1990 to December 2003, 17 patients were diagnosed and treated for actinomycosis in our center. Except 4 patients (involving cervicofacial, and abdominopelvic area), we reviewed the clinical characteristics, diagnosis method, and treatment in 13 patients. RESULT: In 8 patients, the operation was required for diagnosis and treatment. 7 of 8 patients had tumor-like lesions in radiological findings and they were not distinguished as lung cancer, and 1 of 8 patients was non-responsive to the antibiotics therapy. Among the 5 medically treated patients, 4 of 5 patients were diagnosed by bronchoscopic biopsy and one by CT-guided biopsy. All of them was well-responsive by the antibiotic treatment.
CONCLUSION
Thoracic actinomycosis is a chronic inflammatory disease that respond well to antibiotics (penicillin therapy). It should be diagnosed by the repeated biopsy (CT-guided or bronchoscopic) before starting treatment. However, if the lesion is not distinguished as the lung cancer, non-responsive to the medical treatment, and the patients experience the recurrent hemoptysis, we can consider the operation for the diagnosis and treatment.

Keyword

Actinomycosis; Lung infection

MeSH Terms

Actinomycosis*
Anti-Bacterial Agents
Biopsy
Diagnosis
Hemoptysis
Humans
Lung Neoplasms
Anti-Bacterial Agents
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr